Organisation paid for research Program year 2025 Source: CMS Open Payments

William J Rand MD PA

Neither a doctor nor a teaching hospital

Research payments

$998,121

211 payments

Through program year 2025, William J Rand MD PA is reported as receiving $998,121 in research payments, across 211 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$391,791	122
2024	Research	$199,016	35
2023	Research	$27,977	1
2022	Research	$379,337	53

Breakdown

Who paid Research payments · program years 2022–2025

Ocular Therapeutix, Inc. $556,119 155 payments
Genentech, Inc. $370,462 52 payments
Alexion Pharmaceuticals, Inc. $71,539 4 payments

Studies the money was for Research payments · program years 2022–2025

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (axitinib Implant) in Subjects with Neovascular Age-Related Macular Degeneration $556,119 155 payments
Faricimab Dme Long Term Extension Rhone X $155,532 24 payments
A Phase III Study to Evaluate Faricimab in Patients With Central Retinal Vein Occlusion $86,715 7 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $83,277 17 payments
A Phase 2, Double Masked, Placebo Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) $71,539 4 payments
Va2 Phiii Yosemite $39,723 3 payments
Va2 Phiii $5,215 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.